CY1112738T1 - Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη - Google Patents

Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη

Info

Publication number
CY1112738T1
CY1112738T1 CY20121100406T CY121100406T CY1112738T1 CY 1112738 T1 CY1112738 T1 CY 1112738T1 CY 20121100406 T CY20121100406 T CY 20121100406T CY 121100406 T CY121100406 T CY 121100406T CY 1112738 T1 CY1112738 T1 CY 1112738T1
Authority
CY
Cyprus
Prior art keywords
paracetamol
composition containing
combined composition
containing ibuprofen
ibuprofen
Prior art date
Application number
CY20121100406T
Other languages
English (en)
Inventor
Hartley Campbell Atkinson
Original Assignee
Aft Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aft Pharmaceuticals Limited filed Critical Aft Pharmaceuticals Limited
Publication of CY1112738T1 publication Critical patent/CY1112738T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Μία συνδυασμένη φαρμακευτική σύνθεση για τη θεραπεία του πόνου, η οποία περιλαμβάνει 125 mg περίπου έως 150 mg περίπου ιβουπροφαίνης και 475 mg περίπου έως 500 mg περίπου παρακεταμόλης.
CY20121100406T 2004-07-07 2012-04-30 Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη CY1112738T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ53398204 2004-07-07
EP05764510A EP1781277B1 (en) 2004-07-07 2005-07-07 A combination composition comprising ibuprofen and paracetamol

Publications (1)

Publication Number Publication Date
CY1112738T1 true CY1112738T1 (el) 2016-02-10

Family

ID=35783254

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121100406T CY1112738T1 (el) 2004-07-07 2012-04-30 Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη

Country Status (20)

Country Link
US (4) US20080275125A1 (el)
EP (1) EP1781277B1 (el)
JP (1) JP5630943B2 (el)
KR (1) KR101370712B1 (el)
CN (1) CN101022789A (el)
AT (1) ATE543491T1 (el)
AU (2) AU2005260243B2 (el)
BR (1) BRPI0512756A (el)
CA (1) CA2570474C (el)
CY (1) CY1112738T1 (el)
DK (1) DK1781277T3 (el)
ES (1) ES2381794T3 (el)
GB (1) GB2431346C (el)
MX (1) MX2007000117A (el)
PL (1) PL1781277T3 (el)
PT (1) PT1781277E (el)
RU (2) RU2007101686A (el)
SI (1) SI1781277T1 (el)
WO (1) WO2006004449A2 (el)
ZA (1) ZA200700896B (el)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2570474C (en) 2004-07-07 2010-01-05 Aft Pharmaceuticals Limited A combination composition comprising paracetamol and ibuprofen
ZA200803566B (en) * 2005-12-12 2009-10-28 Adcock Ingram Ltd Pharmaceutical compositions
JP5389656B2 (ja) * 2006-10-20 2014-01-15 マクニール−ピーピーシー・インコーポレーテツド アセトアミノフェン／イブプロフェンの組み合わせおよびこれらの使用方法
JP5676834B2 (ja) * 2006-11-29 2015-02-25 エスエス製薬株式会社 消化管への刺激性を減少した経口固形組成物
WO2009012590A1 (en) * 2007-07-23 2009-01-29 Kingsway Pharmaceuticals Inc. Therapeutic formulations for the treatment of cold and flu-like symptoms
US20110124730A1 (en) * 2008-01-03 2011-05-26 Wockhardt Research Centre Oral pharmaceutical suspension comprising paracetamol and ibuprofen
MX340662B (es) 2008-10-14 2016-07-20 Aft Pharmaceuticals Ltd Una combinación medicinal de ibuprofeno y paracetamol para el tratamiento de osteoartritis y artritis reumatoide.
DE102010008876B4 (de) 2010-02-22 2017-07-27 Integrated Micro-Electronics Bulgaria Lichtquelle mit Array-LEDs zum direkten Betrieb am Wechselspannungsnetz und Herstellungsverfahren hierfür
MY164112A (en) * 2010-07-07 2017-11-30 Aft Pharmaceuticals Ltd A combination composition comprising ibuprofen and paracetamol
MX367209B (es) * 2010-11-04 2019-07-22 Aft Pharmaceuticals Ltd Una composición intravenosa que comprende ibuprofeno y paracetamol en combinación.
EP2704697B1 (en) * 2011-05-06 2018-09-12 GlaxoSmithKline Consumer Healthcare (UK) IP Limited Sustained release paracetamol formulations
JP6009928B2 (ja) * 2012-12-14 2016-10-19 ダイハツ工業株式会社 車両のサスペンション
KR102373089B1 (ko) * 2017-03-30 2022-03-11 한미약품 주식회사 이부프로펜 및 아세트아미노펜을 포함하는 약제학적 조성물 및 이의 제조방법
US10376471B2 (en) 2017-07-10 2019-08-13 Gel Cap Technologies, LLC Dual release dosage form capsule and methods, devices and systems for making same
EP3700509B1 (en) 2017-11-29 2023-11-22 Ilko Ilaç Sanayi Ve Ticaret Anonim Sirketi Color stable fixed dose tablet combination of ibuprofen and paracetamol
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
AU2020301401B2 (en) * 2019-06-27 2023-12-21 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Novel ibuprofen and acetaminophen composition
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU605538B2 (en) * 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
CA1336687C (en) * 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
JP3122748B2 (ja) * 1991-11-29 2001-01-09 ライオン株式会社 イブプロフェン含有解熱鎮痛剤
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
ZA959469B (en) 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
KR970000231A (ko) * 1995-06-12 1997-01-21 박형미 진통소염제의 의약조성물
JP3982889B2 (ja) 1997-11-28 2007-09-26 あすか製薬株式会社 イブプロフェン含有医薬製剤
US6440983B1 (en) * 2000-12-21 2002-08-27 Mary Theresa Frank-Kollman Compositions and methods for relieving headache symptoms in aspirin-sensitive headache sufferers
CA2570474C (en) 2004-07-07 2010-01-05 Aft Pharmaceuticals Limited A combination composition comprising paracetamol and ibuprofen
GB0519350D0 (en) 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
US20090264530A1 (en) 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method
MX340662B (es) 2008-10-14 2016-07-20 Aft Pharmaceuticals Ltd Una combinación medicinal de ibuprofeno y paracetamol para el tratamiento de osteoartritis y artritis reumatoide.

Also Published As

Publication number Publication date
ATE543491T1 (de) 2012-02-15
US20140073696A1 (en) 2014-03-13
AU2005260243B2 (en) 2009-10-29
MX2007000117A (es) 2007-06-15
KR101370712B1 (ko) 2014-03-06
WO2006004449A2 (en) 2006-01-12
US20080200549A1 (en) 2008-08-21
EP1781277A4 (en) 2008-09-03
BRPI0512756A (pt) 2008-04-08
JP2008505889A (ja) 2008-02-28
EP1781277A2 (en) 2007-05-09
ZA200700896B (en) 2008-07-30
AU2005260243A1 (en) 2006-01-12
US10532036B2 (en) 2020-01-14
CA2570474C (en) 2010-01-05
DK1781277T3 (da) 2012-05-07
AU2008202029A1 (en) 2009-11-26
EP1781277B1 (en) 2012-02-01
KR20070034614A (ko) 2007-03-28
US20080275125A1 (en) 2008-11-06
WO2006004449A3 (en) 2006-03-02
PL1781277T3 (pl) 2012-07-31
CN101022789A (zh) 2007-08-22
RU2007101686A (ru) 2008-08-20
GB2431346B (en) 2010-01-27
PT1781277E (pt) 2012-05-07
RU2455983C1 (ru) 2012-07-20
ES2381794T3 (es) 2012-05-31
SI1781277T1 (sl) 2012-07-31
JP5630943B2 (ja) 2014-11-26
GB2431346A (en) 2007-04-25
RU2010147287A (ru) 2012-05-27
CA2570474A1 (en) 2006-01-12
GB0700027D0 (en) 2007-02-07
US20110275718A1 (en) 2011-11-10
GB2431346C (en) 2010-02-17

Similar Documents

Publication Publication Date Title
CY1112738T1 (el) Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη
CY1118179T1 (el) Φαρμακευτικη συνθεση
EA200601253A1 (ru) Преимущественно линейная шипучая лекарственная форма фентанила для перорального применения и способы введения
CY1115484T1 (el) Ενωσεις, συνθεσεις και μεθοδοι για την θεραπεια αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων, οπως νοσος alzheimer, διαβητης τυπου 2 και νοσος parkinson
AR047841A1 (es) Metodos y composiciones para el tratamiento de transtornos inmunoinflamatorios
MX2009004203A (es) Combinaciones de paracetamol/ibuprofeno y metodo para su uso.
CY1112387T1 (el) Θεραπευτικη συνθεση περιεχουσα τουλαχιστον ενα παραγωγο της πυρρολοβενζοδιαζεπινης και φλουδαραβινη
EA200601776A1 (ru) Метадоновые композиции местного действия и способы их применения
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
EA200800064A1 (ru) Композиция в виде гранул с модифицированным и немедленным высвобождением мемантина
ECSP077401A (es) Medicamentos que contienen compuestos de carbonilo y su uso
TR200002786T2 (tr) Meloksikam için yeni galenik bir formülasyon.
ATE350377T1 (de) Substituierte 3-pyrrolidin-indol-derivate
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
IL189104A (en) Pharmaceutical preparation containing lasalazide or sodium balasalazide for use in the treatment of gastrointestinal disorders.
DE60336225D1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
DK1383752T3 (da) Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
MA32635B1 (fr) Produit medicamenteux et traitement associe
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
ITMI20022394A1 (it) Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
EA200501223A1 (ru) Терапевтическая система, содержащая амоксициллин и клавулановую кислоту
GEP201606538B (en) Preoperative treatment of post operative pain
RS50523B (sr) Farmaceutska kompozicija koja sadrži cink-hijaluronat kompleks za lečenje multiple skleroze